In a fourth-quarter conference…
In a fourth-quarter conference call, Insmed CEO Will Lewis admitted [...]
In a fourth-quarter conference call, Insmed CEO Will Lewis admitted [...]
An untitled letter shared to the agency’s public database this [...]
Moderna held further discussions with regulators and announced that the [...]
A political movement cannot survive on spite alone.
With $55 billion earmarked to bolster its U.S. operations, Johnson [...]
Shaped primarily by discussions with Gen Xers and older millennials, [...]
The company is confident that results from a head-to-head trial [...]
Six years after the FDA approved Eli Lilly’s Retevmo to [...]
Federal policies under Robert F. Kennedy Jr. that are hostile [...]
Aging means “becoming a target” of the industry, one expert [...]